Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives

Journal of Medicinal Chemistry

Volumn 40, Issue 19, 1997, Pages 2997-3008

  Monte, Aaron P ^a,d   Waldman, Steve R ^a   Marona Lewicka, Danuta ^a   Wainscott, David B ^b   Nelson, David L ^b   Sanders Bush, Elaine ^c   Nichols, David E ^a  

^a PURDUE UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN LA CROSSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (8 METHOXY 2,3,5,6 TETRAHYDROBENZO[1,2 B:5,4 B']DIFURAN 4 YL) 2 AMINOETHANE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (2 AMINOETHYL) 6,7 DIMETHOXY 2,3 DIHYDROBENZOFURAN; CINANSERIN; DIHYDROBENZOFURAN DERIVATIVE; KETANSERIN; LYSERGIDE; MESCALINE; MESULERGINE; PSYCHEDELIC AGENT; RAUWOLSCINE; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONFORMATION; DRUG DESIGN; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG SYNTHESIS; HALLUCINATION; MALE; MOUSE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; RAT;

3T3 CELLS; ANIMALS; BENZOFURANS; BRAIN; HALLUCINOGENS; HUMANS; INDICATORS AND REAGENTS; LETHAL DOSE 50; LYSERGIC ACID DIETHYLAMIDE; MESCALINE; MICE; MOLECULAR STRUCTURE; PHOSPHATIDYLINOSITOLS; RADIOLIGAND ASSAY; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0030823307     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970219x     Document Type: Article

References (68)

1. For parts 1-3 in this series, see refs 32, 33, and 36, respectively.
2. Abstracted in part from the Ph.D. thesis of A. Monte, Purdue University, 1995.
3. Kapadia, G. J.; Fayez, M. B. E. Peyote Constituents: Chemistry, Biogenesis, and Biological Effects. J. Pharm. Sci. 1970, 59, 1699-1727.
4. Heffter, A. Ueber Cacteenalkaloide. Chem. Ber. 1896, 29, 216-227.
5. Späth, E. Uber Die Anhalonium-Alkaloidie. 1. Anhalin and Mezcalin. Monatsh. Chem. 1919, 40, 129-154.
6. Jaffe, J. H. Drug Addiction and Drug Abuse. In The Pharmacological Basis of Therapeutics, 8th ed.; Gilman, A. G., Rall, T. W., Nies, A. S., Taylor, P., Eds.; Pergamon Press: New York, 1990; pp 553-557.
7. Braun, U.; Braun, G.; Jacob, P.; Nichols, D. E.; Shulgin, A. T. Mescaline Analogs: Substitutions at the 4-Position. In NIDA Research Monograph 22, Quantitative Structure-Activity Relationships of Analgesic, Narcotic Antagonists, and Hallucinogens, Barnett, G., Trsic, M., Willette, R., Eds.; U.S. Government Printing Office: Washington, D.C., 1978; pp 27-32.
8. Nichols, D. E.; Glennon, R. A. Medicinal Chemistry and Structure-Activity Relationships of Hallucinogens. In Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives; Jacobs, B. L., Ed.; Raven Press: New York, 1984; pp 95-142.
9. Nichols, D. E. Studies of the Relationship Between Molecular Structure and Hallucinogenic Activity. Pharmacol. Biochem. Behav. 1986, 24, 335-340.
10. Shulgin, A. T.; Shulgin, A. Pihkal: A Chemical love Story; Transform Press: Berkeley, 1991; 978 pp.
11. Nichols, D. E.; Oberlender, R.; McKenna, D. J. Stereochemical Aspects of Hallucinogenesis. In Biochemistry and Physiology of Substance Abuse; Watson, R., Ed.; CRC Press: Boca Raton, 1991; pp 1-39.
12. Nichols, D. E. Medicinal Chemistry and Structure-Activity Relationships. In Amphetamine and Its Analogs; Cho, A. K., Segal, D. S., Eds.; Academic Press, Inc.: San Diego, 1994; pp 3-41.
13. Shulgin, A. T.; Sargent, T.; Naranjo, C. Structure-Activity Relationships of One-Ring Psychotomimetics. Nature 1969, 221, 537-541.
14. Shulgin, A. T.; Dyer, D. C. Psychotomimetic Phenylisopropylamines. 5. 4-Alkyl-2,5-dimethoxyphenylisopropylamines. J. Med. Chem. 1975, 18, 1201-1204.
15. Glennon, R. A. Hallucinogenic Agents as Discriminative Stimuli: A Correlation with Serotonin Receptor Affinities. Psychopharmacohgy 1980, 68, 155-158.
16. Glennon, R. A.; Young, R.; Benington, F.; Morin, R. D. Behavioral and Serotonin Receptor Properties of 4-Substituted Derivatives of the Hallucinogen 1-(2,5-Dimethoxyphenyl) -2-aminopropane. J. Med. Chem. 1982, 25, 1163-1168.
17. 2 Binding Affinity. Eur. J. Pharmacol. 1986, 132, 79-82.
18. 2 Receptors in Guinea Pig Trachea. Eur. J. Pharmacol. 1987 138 115-117
19. 2 Receptors. Mol. Pharmacol. 1987, 31, 194-199.
20. 2 Binding Characteristics with Phenylalkylamine Hallucinogens. Eur. J. Pharmacol. 1988, 145, 291-297.
21. Sanders-Bush, E.; Burris, K. D.; Knoth, K. Lysergic Acid Diethylamide and 2,5-Dimethoxy-4-methylamphetamine are Partial Agonists at Serotonin Receptors Linked to Phosphoinositide Hydrolysis. J. Pharmacol. Exp. Ther. 1988, 246, 924-928.
22. 2 Receptor as a Site of Action for LSD and Phenylisopropylamine Hallucinogens. Psychopharmacology 1988, 94, 213-216.
23. Pierce, P. A.; Peroutka, S. J. Hallucinogenic Drug Interactions with Neurotransmitter Receptor Binding Sites in Human Cortex. Psychopharmacology 1989, 97, 118-122.
24. 2 Serotonin Receptors. J. Med. Chem. 1990, 33, 1032-1036.
25. 2 Serotonin Receptors: Evidence for a Lack of Selectivity. J. Med. Chem. 1992, 35, 734-740.
26. 2 Receptor. Mol. Pharmacol. 1990, 38, 604-609.
27. 2 Receptor Subtypes. Mol. Pharmacol. 1990, 38, 594-598.
28. 1c Cortical Receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1992, 346, 4-11.
29. 1c Receptor Agonists: What Next? In NIDA Research Monograph 146, Hallucinogens: An Update; Lin, G. C., Glennon, R. A., Eds.; NIH Publication No. 94-3872, NIDA: Rockville, 1994; pp 203-213.
30. Nichols, D. E.; Barfknecht, C. F.; Long, J. P.; Stanbridge, R. T.; Howell, H. G.; Partyka, R. A.; Dyer, D. C. Potential Psychotomimetics. 2. Rigid Analogs of 2,5-Dimethoxy-4-methylphenylisopropylamine (DOM, STP) . J. Med. Chem. 1974, 17, 161-166.
31. Nichols, D. E.; Weintraub, H. J. R.; Pfister, W. R.; Yim, G. K. W. The Use of Rigid Analogues to Probe Hallucinogen Receptors. In NIDA Research Monograph 22, Quantitative Structure-Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens; Barnett, G., Trsic, M., Willette, R., Eds.; U.S. Government Printing Office: Washington, D.C., 1978; pp 70-83.
32. Nichols, D. E.; Hoffman, A. J.; Oberlender, R. A.; Riggs, R. M. Synthesis and Evaluation of 2,3-Dihydrobenzofuran Analogues of the Hallucinogen 1-(2,5-Dimethoxy-4-methylphenyl) -2-aminopropane: Drug Discrimination Studies in Rats. J. Med. Chem. 1986, 29, 302-304.
33. Nichols, D. E.; Snyder, S. E.; Oberlender, R.; Johnson, M. P.; Huang, X. 2,3-Dihydrobenzofuran Analogues of Hallucinogenic Phenethylamines. J. Med. Chem. 1991, 34, 276-281.
34. Waldman, S. R.; Monte, A. P.; Bracey, A.; Nichols, D. E. One-Pot Claisen Rearrangement/O-Methylation/Alkene Isomerization in the Synthesis of Ortho-Methoxylated Phenylisopropyl amines. Tetrahedron Lett. 1996, 37, 7889-7892.
35. Monte, A. P.; Marona-Lewicka, D.; Cozzi, N. V.; Nelson, D. L.; Nichols, D. E. Conformationally Restricted Tetrahydro-1-benzoxepin Analogs of Hallucinogenic Phenethylamines. Med. Chem. Res. 1995, 5, 651-663.
36. Monte, A. P.; Marona-Lewicka, D.; Wainscott, D. B.; Nelson, D. L.; Nichols, D. E. Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted 2,5-Dimethoxyphenylalkylanune Derivatives with Rigidified Methoxy Groups. J. Med. Chem. 1996, 39, 2953-2961.
37. Trulson, M. E.; Crisp, T.; Henderson, L. J. Mescaline Elicits Behavioral Effects in Cats by an Action at Both Serotonin and Dopamine Receptors. Eur. J. Pharmacol. 1983, 96, 151-154, and references therein.
38. 77Br]4-Bromo-2,5-dimethoxyamphetamine Labels a Novel 5-Hydroxytryptamine Binding Site in Brain Membranes. Mol. Pharmacol. 1988, 34, 537-542.
39. Barfknecht, C. F.; Nichols, D. E.; Dunn, I., W. J. Correlation of Psychotomimetic Activity of Phenethylamines and Amphetamines with 1-Octanol-Water Partition Coefficients. J. Med. Chem. 1975, 18, 208-210.
40. Nichols, D. E.; Shulgin, A. T.; Dyer, D. C. Directional Lipophilic Character in a Series of Psychotomimetic Phenethylamine Derivatives. Life Sci. 1977, 21, 569-576.
41. Gupta, S. P.; Singh, P.; Bindal, M. C. QSAR Studies on Hallucinogens. Chem. Rev. 1983, 83, 633-649.
42. Jung, M. E.; Abrecht, S. Improved Synthesis of 3-Substituted 7-Methoxybenzofurans. Useful Intermediates for Preparation of Morphine Analogues. J. Org. Chem. 1988, 53, 423-425.
43. Monte, A. P.; Marona-Lewicka, D.; Cozzi, N. V.; Nichols, D. E. Synthesis and Pharmacological Examination of Benzofuran, Indan, and Tetralin Analogues of 3,4-(Methylenedioxy) amphetamine. J. Med. Chem. 1993, 36, 3700-3706.
44. Short, J. H.; Dunnigan, D. A.; Ours, C. W. Synthesis of Phenethylamines from Phenylacetonitriles Obtained by Alkylation of Cyanide Ion with Mannich Bases from Phenols and Other Bensylamines. Tetrahedron 1973, 29, 1931-1939.
45. Aboul-Enein, M. N.; Eid, A. I. A Novel Route for the Synthesis of Mescaline. Acta Pharm. Suec. 1979, 16, 267-270.
46. Carvalho, C. F.; Sargent, M. V. Boron Trichloride as a Selective Demethylating Agent for Hindered Ethers. J. Chem. Soc., Chem. Commun. 1984, 227-229.
47. Caldwell, W. T.; Thompson, T. R. Nuclear Methylation of Phenols. A New Synthesis of Intermediates in the Preparation of Antisterility Factors. J. Am. Chem. Soc. 1939, 61, 765-767.
48. Dallacker, F.; Meunier, E.; Limpens, J.; Lipp, M. Preparations of Derivatives of Trimethoxybenzene. Monatsch. 1960, 91, 1077-1088.
49. Friedman, L.; Schecter, H. Preparation of Nitriles from Halides and Sodium Cyanide. An Advantageous Nucleophilic Displacement in Dimethyl Sulfoxide. J. Org. Chem. 1960, 26, 877-879.
50. Yoon, N. M.; Pak, C. S.; Brown, H. C.; Krishnamurthy, S.; Stocky, T. P. Selective Reductions. XIX. The Rapid Reaction of Carboxylic Acids with Borane-Tetrahydrofuran. A Remarkably Convenient Procedure for the Selective Conversion of Carboxylic Acids to the Corresponding Alcohols in the Presence of Other Functional Groups. J. Org. Chem. 1973, 38, 2786-2792.
51. Nichols, D. E.; Barfknecht, C. F.; Rusterholz, D. B.; Benington, F.; Morin, R. D. Asymmetric Synthesis of Psychotomimetic Phenylisopropylamines. J. Med. Chem. 1973, 16, 480-483.
52. Lewin, A. H.; Parker, S. R.; Fleming, N. B.; Carroll, F. I. Formylation of Arenes by α,α-Dichloromethyl Methyl Ether. An Improved Experimental Procedure. Org. Prep. Proc. Int. 1978, 10, 201-204.
53. Monte, A. P.; Marona-Lewicka, D.; Kanthasamy, A.; Sanders-Bush, E.; Nichols, D. E. Stereoselective LSD-like Activity in a Series of d-Lysergic Acid Amides of (R) - and (S) -2-Aminoalkanes. J. Med. Chem. 1995, 38, 958-966.
54. Nichols, D. E.; Huffman, A. J.; Oberlender, R. A.; Jacob, P., III; Shulgin, A. T. Derivatives of 1-(1,3-Benzodioxol-5-yl) -2-butanamine: Representatives of a Novel Therapeutic Class. J. Med. Chem. 1986, 29, 2009-2015.
55. De Boer, T. J.; Backer, H. J. Diazomethane. Organic Syntheses; Wiley: New York, 1963; Collect. Vol. IV, pp 250-253.
56. Black, T. H. The Preparation and Reactions of Diazomethane. Aldrichimica Acta 1983, 16, 3-10.
57. Oberlender, R.; Nichols, D. E. Drug Discrimination Studies With MDMA and Amphetamine. Psychopharmacoloey 1988, 95, 71-76.
58. Oberlender, R.; Nichols, D. E. (+) -N-Methyl-1-(1,3-Benzodioxol5-yl) -2-Butanamine as a Discriminative Stimulus in Studies of 3,4-Methylenedioxymethamphetamine-Like Behavioral Activity. J. Pharmacol. Exp. Ther. 1990, 255, 1098-1106.
59. Litchfield, J. T.; Wilcoxon, F. A Simplified Method of Evaluating Dose-Effect Experiments. J. Pharmacol. Exp. Ther, 1949, 96, 99-113.
60. 2 Receptor in Rat Frontal Cortex. Pharmacol. Biochem. Behav. 1990, 35, 211-217.
61. 2F Receptor. Mol. Pharmacol. 1993, 4, 419-426.
62. Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976, 72, 248-254.
63. 2 Receptor: Structurally Specific Differentiation by Ergolines and Tryptamines. J. Pharmacol. Exp. Ther. 1993, 265, 1272-1279.
64. 2B) Receptor. Soc. Neurosci. Abstr. 1995, 21, Part 2: 1124.
65. Pazos, A.; Hoyer, D.; Palacios, J. M. Mesulergine, a Selective Serotonin-2 Ligand in the Rat Cortex, Does not Label these Receptors in Porcine and Human Cortex: Evidence for Species Differences in Brain Serotonin-2 Receptors. Eur. J. Pharmocol. 1985, 106, 531-538.
66. 50) of an Enzymatic Reaction. Biochem, Pharmacol. 1973, 22, 3099-3108.
67. Berridge, M. J.; Downes, C. P.; Hanley, M. R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 1982, 206, 587-595.
68. Grotowiel, M. S.; Sanders-Bush, E. Regulation of serotonin2A receptors in heterologous expression systems. J. Neurochem. 1994, 63, 1255-1260.